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Objectives:  To examine whether the Functional Data Analysis (FDA), Statistical Parametric 
Mapping (SPM) and Statistical non-Parametric Mapping (SnPM) hypothesis testing techniques differ 
in their ability to draw inferences in the context of a single, simple experimental design. 
Design: The sample data used is cross-sectional (two-sample gender comparison) and 
evaluation of differences between statistical techniques used a combination of descriptive and 
qualitative assessments.  
Methods: FDA, SPM and SnPM t-tests were applied to sample data of twenty highly skilled 
male and female rowers, rowing at 32 strokes per minute in a single scull boat. Statistical differences 
for gender were assessed by applying two t-tests (one for each side of the boat).  
Results: The t-statistic values were identical for all three methods (with the FDA t-statistic 
presented as an absolute measure). The critical t-statistics (tcrit) were very similar between the 
techniques, with SPM tcrit providing a marginally higher tcrit than the FDA and SnPM tcrit values 
(which were identical). All techniques were successful in identifying consistent sections of the force 
waveform, where male and female rowers were shown to differ significantly (p < 0.05).  
Conclusions: This is the first study to show that FDA, SPM and SnPM t-tests provide 
consistent results when applied to sports biomechanics data. Though the results were similar, selection 
of one technique over another by applied researchers and practitioners should be based on the 
underlying parametric assumption of SPM, as well as contextual factors related to the type of 
waveform data to be analysed and the experimental research question of interest.  
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A force profile analysis comparison between functional data analysis, statistical parametric 
mapping and statistical non-parametric mapping in on-water single sculling. 
 
Introduction 
The ability to statistically analyse whole movements using biomechanical data is of 
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biomechanical time-series variables (also referred to as waveforms, curves, etc.). Differences between 
individuals for characteristics of these variables (i.e. the shape of the these curves when observed 
graphically), has led to terms such as movement ‘signatures’ being used2. The most commonly used 
approach for the analysis of these waveform variables however is discrete point analysis (DPA)3, 
which reduces the dimensionality of a waveform by examining pre-selected ‘key’ data points (e.g. 
maxima or minima). Despite its common implementation in applied biomechanics settings, this 
approach can be limiting, as pre-selection of key points is often dependent on a priori knowledge of 
the movement being analysed, and can thus lead to potentially relevant information being discarded3. 
This can be become problematic in biomechanics, as research is can often be exploratory prior to the 
generation of hypotheses when analysing time-series data4.  
Some well-established statistical methods, which allow statistical examination of entire time-
series have increased in popularity in human movement research. These are Functional Data Analysis 
(FDA)5 and Statistical Parametric Mapping (SPM)6. The general concept of FDA is to express 
discrete observations arising from time-series in the form of a function, and then consider each 
measured function as a single observation for subsequent statistical analysis. This has led to the 
adaptation of several accepted statistical practices that are commonly used for data reduction (i.e. 
PCA), clustering, hypothesis testing techniques (i.e. functional linear models) and forecasting (for a 
comprehensive contemporary review see: Ullah & Finch7). Within the realm of human movement 
analysis, FDA has been applied in a range of sports biomechanics studies including, but not limited to, 
the analysis of race-walking, running, jumping, weightlifting and rowing8-14. SPM also regards time-
series variables as a single observation. SPM exploits the use of random field theory (RFT)15 to 
directly map the conventional Gaussian distribution to smooth n-dimensional continua, providing an 
objective framework for hypothesis testing using parametric statistical concepts. SPM has also been 
adapted for non-parametric analyses16, and this is referred to as Statistical non-Parametric Mapping 
(SnPM). Similar to FDA, SPM (and SnPM) have demonstrated application in human movement 
contexts such as the analysis of biomechanical time-series data in soccer kicking, running and cutting 
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The recent proliferation of these statistical methods in biomechanics is partly due to their 
increasing availability. Software for the implementation of FDA and SPM is freely available and 
written for use with a number of statistical programs. FDA software is available from the 
www.functionaldata.org website, and is designed for use with Matlab, R and S-Plus. Similarly, SPM 
software is available for use from the www.spm1d.org website, and is designed for use with Matlab 
and Python. Despite being different statistical methods for analysing waveform data, there are some 
techniques within FDA and SPM that mirror conventional statistical concepts from classical 
hypothesis testing. One such statistical test is the independent samples t-test. In both FDA and SPM, a 
t-statistic is generated in the form of a continuous trajectory and random data is used to develop a 
critical t-statistic threshold for significance testing between independent samples. At present, the 
independent sample t-test has been applied in the context of FDA22, SPM23 and also SnPM24 with 
biomechanical data. Despite this, to the best of the authors’ knowledge there has never been a formal 
comparison of these statistical approaches in the context of human movement data.  
This paper examines the FDA, SPM and SnPM independent sample t-tests when applied to 
sample rowing biomechanics data, to test the hypothesis of gender differences in sculling. 
Understanding gender differences in rowing has practical relevance in sports biomechanics, as it can 
provide insights into the need for gender specific training interventions and evaluation of injury 
mechanisms. At present there is established support for presence of biomechanical differences 
between male and female rowers for discrete biomechanical variables, with peak force and peak 
power differences noted between males and females25. Additionally, patterns of relative force-angle 
profiles (normalized to 100% of maximum force) have also been found to differ relative to gender14. 
Thus it can be hypothesised from these previous findings that differences between these samples of 
rowers may exist in the amount of force application applied across sections of the drive phase, 
however this is largely an exploratory analysis using each of the statistical approaches. The goal was 
to qualitatively compare the results of FDA, SPM and SnPM for an example dataset, and subsequently 

















Following institutional ethical approval and participant consent, ten male (M age = 21.87 + 
2.55 years; M height = 1.91 + 0.06 m; M mass = 87.16 + 9.14 kg) and ten female (F age = 20.73 + 
3.65 years; F height = 1.82 + 0.06 m; F mass = 72.47 + 7.08 kg) highly trained heavyweight and 
lightweight scullers participated. All rowers were required to have competed in an Australian national 
age group championship or an Australian national open championship (i.e. national level athlete) or 
represented Australia at an under 18, 23, or open level event (i.e. international level athlete) prior to 
testing.  
Participants were instructed to row a total of 1000 m, composed of four 250 m segments at 
ascending pre-selected stroke rates of 20, 24, 28 and 32 strokes per minute. Only the 32 strokes per 
minute data (i.e., a race representative stroke rate) were analysed. Rowing data was obtained using 
ROWSYS instrumentation (see Smith and Loschner26 for a full description of the system), and the 
propulsive component (relative to the longitudinal axis of the boat) of force was retained and 
analysed. The same ten strokes were selected for the bow and stroke side for each rower (these sides 
of the boat are sometimes also referred to as starboard and port-side). These strokes were performed 
simultaneously and consecutively. For each participant, the drive and recovery phases were identified 
using the horizontal oar angle and only the drive phase was analysed in this study. A linear length 
normalization strategy using an interpolating cubic spline was applied, registering each curve to 100% 
of the drive phase. An average waveform created from each participant’s ten strokes (for both boat-
sides) was used for further analysis. This resulted in a total of twenty curves for each independent 
samples t-test. Prior to analysis, data was filtered using a dual low-pass Butterworth filter with a cut-
off frequency of 5Hz.  
For the FDA, SPM and SnPM t-tests α = 0.05. Prior to conducting the FDA independent t-
test, the force trajectories were estimated as functions using B-splines5. Data was also smoothed as a 
part of FDA by adding a roughness penalty to the fitting procedure. A very small roughness penalty 
was used (1 x 10-100) to avoid introducing any differences between FDA, SPM and SnPM that were a 
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entire movement using the following two equations. The FDA t-statistic [FDA T(t)] was calculated as 
27, 28:  
 











Where, 𝑥1(𝑡) and 𝑥2(𝑡) are the force trajectories for males and females and ?̅?1(𝑡) and ?̅?2(𝑡) are 
the pointwise means for the male and female trajectories, n1 and n2 denote the sample sizes in male 
and female trajectories respectively and Var[x1(t)] and Var[x2(t)] denote the variance for male and 
female trajectories respectively. The pointwise t-statistic for both SPM and SnPM [SPM & SnPM 
T(t)] is identical (equation below), however it is directional as the numerator of 𝑇(𝑡) is not absolute 
(similar to Welch’s original definition of the conventional t-statistic):  
 











Calculation of the critical t-statistic for the FDA t-test (FDA-tcrit) was determined using a 
permutation test by randomly shuffling the male and female labels on the trajectories and calculating 
the maximum of 𝑇(𝑡) using these new labels28. The maximum number of permutations possible for 
this data was used to create a null distribution (184,756 permutations or 20!/(10!×10!)). For each 
permutation the maximum t-value (tmax) is saved, resulting in a distribution of tmax values. The FDA-
tcrit is then given as the 100 × (1 – α)th percentile of the tmax distribution. The critical t-statistic for the 
SPM t-test (SPM-tcrit) is given by RFT15 as the solution to: 
 
𝑃(𝑇(𝑡)𝑚𝑎𝑥 > 𝑡𝑐𝑟𝑖𝑡) = 1 − exp (− ∫ 𝑓𝑝𝑑𝑓(𝑥) 𝑑𝑥 − 𝐸𝐷
∞
𝑡𝑐𝑟𝑖𝑡
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Where T(t)max is the maximum value of the continuous trajectory, tcrit is the SPM-tcrit, fpdf(x) is 
the t-statistic’s probability density function and ED is the smoothness-dependent Euler density 
function6. Similar to the conventional t-test, the above equation represents the probability that T(t)max 
exceeds SPM-tcrit when the underlying data refers directly to random processes with Gaussian kernel 
24. Identically to the FDA-tcrit, the t-statistic for the SnPM t-test (SnPM-tcrit) is calculated using the 
permutation method implemented by Nichols and Holmes16 and is summarized comprehensively in 
Pataky, Vanrenterghem and Robinson24. Again, the maximum number of permutations possible for 
this data was used to create a null distribution (this was 184,756 permutations).  
FDA, SPM and SnPM t-tests were conducted independently, for each side of the boat to test 
for gender differences in the drive phase (continuous application of propulsive force). For each t-test, 
the critical t-statistic and areas of significance between the two groups were reported. Descriptive 
comparisons of the critical t-statistic thresholds for the FDA, SPM and SnPM t-tests and any 
associated areas of significance (or regions) was also used as the criterion for comparing each of the 
statistical techniques.  
 
Results 
For the bow-side, the FDA-tcrit = 3.20, the SPM-tcrit = 3.33 and the SnPM-tcrit = 3.20. FDA, 
SPM and SnPM t-tests each identified two separate parts of the drive phase that differed significantly 
between males and females (α = 0.05). Firstly, a region spreading from 28%-82% of the drive phase 
was found to differ significantly for gender, with each method (FDA p < 0.001; SPM p < 0.001; 
SnPM p < 0.001). Secondly, a region spreading from 90%-96% of the drive phase was found to differ 
significantly for gender with each method (FDA p < 0.001; SPM p = 0.040; SnPM p < 0.001).  
For the stroke side, the FDA-tcrit = 3.18, the SPM-tcrit = 3.33 and the SnPM-tcrit = 3.18. FDA, 
SPM and SnPM t-tests each identified one part of the drive phase that significantly differed between 
males and females (α = 0.05). This region spread from 26%-82% of the drive phase was found to 
significantly differ for gender with each method (FDA p < 0.001; SPM p < 0.001; SnPM p < 0.001). 
For the bow-side and stroke-side comparisons, the t-statistic trajectories for the FDA, SPM and SnPM 
















This study compared the results of the FDA, SPM and SnPM t-tests in the identification of 
differences in propulsive force application for gender using a sample rowing data set. All three 
techniques provided similar results, and in each case significant differences were identified for 
gender, with significantly different sections of the force curve present across both sides of the boat. 
These sections were identical for each t-test. All three t-tests demonstrated that male rowers were 
significantly more likely to apply a higher level of force leading into and away from the point of 
maximum force on both sides of the boat. As anticipated, these results are consistent with previous 
findings related to kinetic differences between male and female rowers25.  
From a statistical perspective, there are several noteworthy findings for future application of 
these techniques in biomechanics. The t-statistics calculated as a part of each approach were 
numerically identical, with the exception that the SPM and SnPM t-statistics are directional, and thus 
provide a potentially more informative graph for inspection of differences between independent 
groups. Of particular note, the SPM Matlab function ttest2 and the SnPM Matlab function 
nonparam.ttest2 allow the possibility for conducting either a one-tailed or two-tailed t-test, 
whereas the tperm_fd Matlab function for the FDA t-test only provides a two-tailed option. This is 
something that should be considered when setting the alpha level for future use of the FDA technique.  
The FDA-tcrit, SPM-tcrit and SnPM-tcrit values were very similar (with the FDA-tcrit and the 
SnPM-tcrit providing identical values). This led to global consistency between the techniques in 
identifying of statistically significant sections of difference between genders for their respective force 
curves.  Two sections of the curve were identified for the bow-side and one section of the curve was 
identified for the stroke-side. The small differences in tcrit values between each of these techniques is 
partly due to the different processes implemented for the generation of the null distribution. Generally 
speaking, parametric hypothesis testing techniques (e.g. cross-sectional, longitudinal, regression, etc.), 
are typically considered to be a part of the general linear model (GLM) framework. SPM applies the 
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followed by parametric inference and corrections for multiple comparisons via RFT6. Such parametric 
approaches assume that the residual trajectories are normally distributed. Conversely, permutation 
tests such as the FDA and SnPM t-tests in the present study are nonparametric and rely on the less 
inclusive assumption of exchangeability: under the permutation-test null hypothesis31. In the present 
study, both groups of curves are believed to be generated by a single distribution, where the 
independent and identically distributed observations are exchangeable. It is entirely plausible that 
these different (parametric vs non-parametric) approaches for generation of the null distribution, could 
have led to the small difference noted between the tcrit for SPM and the tcrit for non-parametric tests 
(FDA and SnPM). When explored in the context of imaging data, permutation tests have been 
demonstrated to be generally more stringent than parametric tests (i.e. stronger control over Type-1 
errors) and more robust to random noise in imaging measurements31. The results from the present 
study are somewhat opposed to these findings, where the SPM-tcrit was higher than the tcrit for the 
permutation tests. There are some potential reasons for this finding. Firstly, parametric approaches 
such as SPM make assumptions regarding the presence of normality16. Such strategies can become 
prone to false findings when this underlying assumption is invalid. It is possible that this may have 
influenced results in the present study. Additionally, small sample sizes like that noted in the present 
study (10 trajectories per sample) can lead to insufficiently small numbers of permutations for 
building a null distribution. This can also potentially affect calculation of tcrit for the permutation tests, 
although this was unlikely to have a strong affect in the present study as a large number of 
permutations were used (over 100,000). Given the similarity of all critical t-statistic thresholds, the 
choice between parametric (SPM) and non-parametric (FDA and SnPM) t-tests in the present study 
had negligible effects on the current results suggesting that RFT’s assumption of waveform based 
Gaussian randomness was reasonable for the current data set, with this also previously demonstrated 
to be true with other biomechanical data24. Similarly, there were no notable differences between the 
functional approach used in the FDA t-test (representing the data as coefficients of equations), and the 
SPM and SnPM methods (where in the present study the data was represented as a vector of points). 
Further to this, the permutation approaches outlined for the FDA t-test and the SnPM t-test are 
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conducted (i.e. functional data opposed to a vector or points). To the best of the authors’ knowledge, 
this is the first paper to demonstrate theoretical statistical equivalence between these two non-
parametric approaches. Additionally, this paper indicates that when smoothing is controlled for during 
FDA, no registration techniques are applied for temporal misalignments of data post normalization5, 
and parametric assumptions underpinning the data hold true, FDA, SPM and SnPM results are very 
similar.  
In light of these results it could be asked whether there is an optimal statistical approach 
amongst FDA, SPM and SnPM when applying the independent samples t-test? In short, the answer is 
that there is no optimal method. There are some reasons however, why researchers and practitioners 
may opt to select one method over another for hypothesis testing of waveform data. Firstly, and as 
outlined by Pataky, Vanrenterghem and Robinson24, the main benefit of SPM (and RFT) tests is that, 
since they assume an analytical model of randomness and they are computationally fast. Conversely, 
non-parametric procedures are computationally slower because they build randomness models 
iteratively. Similar to conventional parametric hypothesis testing approaches, a substantial issue for 
their application is the violation of the assumption for a Gaussian distribution of randomness. Pataky, 
Vanrenterghem and Robinson24 have noted that adherence to the normality assumption should be 
assessed prior to using parametric procedures, either explicitly through a test for normality, or 
implicitly by checking for agreement between parametric and non-parametric results. At present, 
methods adapted for testing normality of waveform data in biomechanical literature is limited, 
however, some methods have been suggested and used in imaging research32, with this being a 
potential area of exploratory interest in human movement research. Additionally, the FDA and SnPM 
permutation approaches in the present study are less susceptible to spurious results when smaller 
sample sizes are used, and may be of benefit in those contexts in biomechanical research24.  
Some caution is advised however for applying the FDA and SnPM approaches in future 
research. As both of these are non-parametric permutation methods, they rely upon the user to 
designate a suitable number of permutations to build the null distribution. If the maximum number of 
permutations is not selected, this will lead to the generation of a different critical t-threshold every 
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techniques should aim to use the maximum number of permutations possible (or use a suitable large 
minimum number of permutations, i.e. 100,000). Unlike FDA and SnPM, the SPM critical t-threshold 
will always be stable. Additionally, for the non-parametric FDA t-test it should also be noted that a 
negligible smoothing parameter was added to the data as a part of fitting B-Splines to the trajectories. 
It should be cautioned that the addition of a smoothing parameter to previously filtered data is 
unnecessary, and should be avoided in future experimental research. A smoothing parameter was 
added in the present study as the MATLAB software requires the integration of a smoothing 
parameter as a part of the function fitting process.  
Each statistical method also allows for some unique benefits, which may suit researchers 
depending upon the context of their research question and also the type of data involved in the study. 
FDA and SPM are useful for smooth waveform data, however FDA provides researchers with control 
over the amount and type of smoothing, registration of functions to separate amplitude and phase 
variation, and also allows for accurate calculation of derivatives, which can be more effective for 
registering functions in some instances5. It should also be mentioned that FDA techniques would 
generally not be applied using the method outlined in the present study. Despite control over 
smoothing being integral to the comparison of FDA and SPM in this study, smoothing is considered 
to be an integral feature of FDA, and the extent to which data are smoothed normally involves careful 
consideration and pre-selection using approaches such as generalized cross validation (GCV)5.  
There may also be occasions where SPM and SnPM are considered as more suitable 
alternatives to FDA, with one such example being when a variable has important temporal variations 
in frequency content, thus making it difficult for a single basis expansion approach (B-splines, 
Fourier, wavelets, etc.) to adequately represent the original data as coefficients of an equation (i.e. in 
the example of running gait, high frequency content in ground reaction force at foot-strike and then 
lower frequency content throughout the rest of the stance phase). Additionally, as SPM and SnPM 
treats data as a vector of points, these approaches are more flexible for a priori selection of important 
regions of interest (ROI) on a waveform33, and allows for hypothesis testing to take place on these 
ROIs (thus influencing statistical power), rather than the whole vector. This is not possible within 
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within a waveform will change the critical t-threshold for a given alpha level (as the smoothness of 
the curve will change, thus influencing the outcomes of RFT). Researchers, therefore, must have a 
strong rationale for pre-selection of a section of a movement to be analysed, as the results of an ROI 
analysis will likely change, when compared to SPM or SnPM being applied to the entire time-series33. 
Finally, it should also be acknowledged that there are advancements in FDA beyond the scope 
of the FDA technique applied in the present study34. From the perspective of FDA hypothesis testing 
techniques it appears that there are two main approaches (parametric and non-parametric), which fall 
within basis function approximation methods and overall tests. With reference to procedures 
concerned with testing the equality of coefficients from a basis function approximation, parametric 
methods include the works of Fan and Li35, Cuevas et al.,36 and Spitzner37; and nonparametric 
methods include the work of Zhang and Chen38, Mohdeb et al.,39 and Cao et al.40. The FDA t-test used 
in the present study28 was explored due to its implementation with biomechanical data in experimental 
human movement research, and also the ease with which software can be accessed by applied 
clinicians and researchers from the FDA website.  
 
Conclusion 
The FDA, SPM and SnPM statistical methods all came to the same inferential conclusions (t-
test) using this sample data set, despite possessing alternative approaches for representation of the raw 
time-series data and estimation of the null distribution. As such, it is likely that selection of one 
technique over another will likely be due to the type of data being used and the nature of the 
experimental research question involved. This is also the first study to demonstrate statistical 
equivalence of the FDA t-test and SnPM t-tests.  
 
Practical Implications 
 The SPM t-test is suited for application to parametric distributions of curves, and may also be 
useful when it is desirable to explore key ROIs on a waveform, or manage a signal with high 
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 The SnPM t-test is suited for application to non-parametric distributions of curves, and like 
SPM, may be useful when it is desirable to explore key ROIs on a waveform, or manage a 
signal with high and low frequency content.  
 The FDA t-test is suited for application to non-parametric distributions of curves, and is 
practically useful when fine control over the smoothing and registration (i.e. separation of 
phase and amplitude variation and temporal alignment) of data is of interest for particular 
experimental research questions. 
**These points pertain to current software implementations for each of these techniques. 
Modifications to these software packages may lead to changes in the benefits of some of these 
techniques in the future. 
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Figure 1:  Results of the FDA, SPM and SnPM t-tests for gender differences. Top left: mean and 
standard deviation clouds for the male rowers (blue) and female rowers (red) for the bow-
side. Top right: mean and standard deviation clouds for the male rowers (blue) and female 
rowers (red) for the stroke-side. Middle left: The bow-side pointwise FDA t-statistic, with 
the FDA-tcrit (green). Middle right: The stroke-side pointwise FDA t-statistic, with the 
FDA-tcrit (green). Bottom left: The bow-side pointwise SPM and SnPM t-statistic, with the 
SPM-tcrit (blue) and the SnPM-tcrit (red). Bottom right: The stroke-side pointwise SPM and 
SnPM t-statistic, with the SPM-tcrit (blue) and the SnPM-tcrit (red). 
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